BCL-2 Is a Prognostic Marker and Its Silencing Inhibits Recurrence in Ameloblastomas

Oral Diseases - United Kingdom
doi 10.1111/odi.13070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Article on BCL-2 as a Prognostic Marker

Clinical Cancer Research
Cancer ResearchOncology
2006English

Lrig1 Is a Positive Prognostic Marker in Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Grouper Iridovirus GIV66 Is a BCL-2 Protein That Inhibits Apoptosis by Exclusively Sequestering Bim

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

BCL-2 Family Members as Prognostic Indicators in AML

Hematology
Hematology
2002English

BubR1 as a Prognostic Marker for Recurrence-Free Survival Rates in Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
2009English

BCL-2 Oncoprotein Expression in Breast Cancer, Its Relation to Estrogen and Progesterone Receptors and Other Prognostic Factors

Annals of the College of Medicine, Mosul
2009English

Is BCL-2 a Predictive Marker of Neoadjuvant Chemotherapy Response in Patients With Urothelial Bladder Cancer Undergoing Radical Cystectomy?

Scandinavian Journal of Urology
UrologyNephrology
2019English

BCL-2 Protein as a Marker of Neuronal Immaturity in Postnatal Primate Brain

Journal of Neuroscience
Neuroscience
1998English

2-Deoxyglucose-Induced Toxicity Is Regulated by BCL-2 Family Members and Is Enhanced by Antagonizing BCL-2 in Lymphoma Cell Lines

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy